Looking for biogenic magnetite in brain ferritin using NMR relaxometry

NMR in Biomedicine

Volumn 18, Issue 7, 2005, Pages 469-472

  Gossuin, Yves ^a   Hautot, Dimitri ^b,c   Muller, Robert N ^a   Pankhurst, Quentin ^b   Dobson, Jon ^c   Morris, Chris ^d   Gillis, Pierre ^a   Collingwood, Joanna ^c  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Brain; Ferritin; Magnetite; Magnetoferritin; Relaxometry

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; BRAIN; DISEASES; ELECTRON DIFFRACTION; MAGNETIC RELAXATION; MAGNETITE; PARTICLES (PARTICULATE MATTER); TRANSMISSION ELECTRON MICROSCOPY;

BIOGENIC MAGNETITE; BRAIN FERRITIN; MAGNETOFERRITIN; RELAXOMETRY;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

FERRITIN; IRON; MAGNETITE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CALIBRATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RELAXATION TIME; TRANSMISSION ELECTRON MICROSCOPY;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN CHEMISTRY; CALIBRATION; FEMALE; FERRITINS; FERROSOFERRIC OXIDE; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EQUUS CABALLUS; MAMMALIA;

EID: 27844584309     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.983     Document Type: Article

References (20)

1. Kirschvink JL, Kobayashikirschvink A, Woodford BJ. Magnetite biomineralization in the human brain. Proc. Natl. Acad. Sci. USA 1992; 89: 7683-7687.
2. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett. 2001; 496: 1-5.
3. Schultheiss-Grassi PP, Wessiken R, Dobson J. TEM investigations of biogenic magnetite extracted from the human hippocampus. Biochim. Biophys. Acta Gen. Subj. 1999; 1426: 212-216.
4. Dobson J. Magnetic iron compounds in neurological disorders. Ann. N. Y. Acad. Sci. 2004; 1012: 183-192.
5. Hautot D, Pankhurst QA, Kahn N, Dobson J. Nanoscale biogenic magnetite and Alzheimer's disease. Proc. R. Soc. London B Suppl. 2003; 270: S62.
6. Quintana C, Cowley JM, Marhic C. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. J. Struct. Biol. 2004; 147: 166-178.
7. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996;1275:161-203.
8. Cornell RM, Schwertmann U. The Iron Oxides. VCH: Weinheim, 1996.
9. Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem. Phys. 1999; 110: 5403-5411.
10. Bulte JW, Vymazal J, Brooks RA, Pierpaoli C, Frank JA. Frequency dependence of MR relaxation times. II. Iron oxides. J. Magn. Reson. Imaging 1993; 3: 641-648.
11. Gossuin Y, Roch A, Muller RN, Gillis P, Lo Bue F. Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn. Reson. Med. 2002; 48:959-964.
12. Gossuin Y, Roch A, Lo Bue F, Muller RN, Gillis P. Nuclear magnetic relaxation dispersion of ferritin and ferritin-like magnetic particle solutions: a pH-effect study. Magn. Reson. Med. 2001; 46: 476-481.
13. Gossuin Y, Roch A, Muller RN, Gillis P. An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents. J. Magn. Reson. 2002; 158: 36-42.
14. Meldrum FC, Heywood BR, Mann S. Magnetoferritin - in vitro synthesis of a novel magnetic protein. Science 1992; 257: 522-523.
15. Bulte JWM, Douglas T, Mann S, Frankel RB, Moskowitz BM, Brooks RA, Baumgartner CD, Vymazal J, Strub MP, Frank JA. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J. Magn. Reson. Imaging 1994; 4: 497-505.
16. Dedman DJ, Treffry A, Candy JM, Taylor GAA, Morris CM, Bloxham CA, Perry RH, Ewardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's disease and chronic renal-dialysis patients. Biochem. J. 1992; 287: 509-514.
17. 2 of ferritin at different field strengths: effect on MRI. Magn. Reson. Med. 1992; 27: 368-374.
18. Gossuin Y, Roch A, Muller RN, Gillis P. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn. Reson. Med. 2000; 43: 237-243.
19. Weiss BP, Kim SS, Kirschvink JL, Kopp RE, Sankaran M, Kobayashi A, Komeili A. Ferromagnetic resonance and low-temperature magnetic tests for biogenic magnetite. Earth Planet. Sci. Lett. 2004; 224: 73-89.
20. Zecca L, Gallorini M, Shunemann V, Trautwein AX, Gerlach M, Riederer P, Vezzoni P, Tampellini D. Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages. Consequences for iron storage and neurodegenerative processes. J. Neurochem. 2001; 76: 1766-1773.